跳至主要内容
临床试验/JPRN-UMIN000013496
JPRN-UMIN000013496已完成未知

Effect of intravenous immunoglobulin (IVIG) in pregnant women with refractory obstetric antiphospholipid syndrome: A prospective single-arm interventional study - Effect of intravenous immunoglobulin (IVIG) in pregnant women with refractory obstetric antiphospholipid syndrome: A prospective single-arm interventional study

ational Center for Child Health and Development0 个研究点目标入组 8 人开始时间: 2014年3月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1 History of drug hypersensitivity 2 History of heparin-induced thrombocytopenia 3 Hereditary fructose intolerance 4 IgA deficiency 5 Uterine anomalies, uterine submucosal myomas, or intrauterine tumors more than 10 cm in diameter 6 Inability to obtain written informed consent 7 Abnormal laboratory blood test results: Platelets are less than 50000/mm3 ALT, ALT, LDH, and ganma-GTP are more than 1.5 times the upper limit at each institution Plasma creatinine is more than 0.8 mg/dl

研究者

发起方
ational Center for Child Health and Development

相似试验